RESOURCESReview our scientific literature


Protein Assay List

Target 96

Oncology ii

Oncology iii

Cardiovascular ii (CVD ii)

Cardiovascular iii (CVD iii)


Mouse Exploratory

SERVICESBoost your research with Translational Power

Supporting your clinical research needs with targeted analyses and clinical trial expertise.
Target 48


Mouse Cytokine

SERVICESBoost your research with Translational Power

Supporting your clinical research needs with targeted analyses and clinical trial expertise.


Cardiovascular Diseases

Michaëlsson E, Lund LH, Hage C, et al. Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF. (2023) JACC. Heart Failure, DOI: 10.1016/j.jchf.2023.03.002

Association between proteomic biomarkers and myocardial fibrosis measured by MRI: the multi-ethnic study of atherosclerosis. (Hooman et al, 2023) DOI:

Nurmohamed NS, Kraaijenhof JM, Mayr M, et al. Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction. (2023) European Heart Journal, DOI: 10.1093/eurheartj/ehad161

Infectious Diseases

Proteomic Analysis of Mucosal and Systemic Responses to SARS-CoV-2 Antigen. (Martinson et al., 2023) DOI: 10.3390/vaccines11020334

Longitudinal proteomic profiling of the inflammatory response in dengue patients. (Garishah et al.,2023) DOI: 10.1371/journal.pntd.0011041

Optimizing a Diagnostic Model of Periodontitis by Using Targeted Proteomics. (Reckelkamm et al., 2023) DOI: 10.1021/acs.jproteome.3c00230

A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes. (Chowdhury et al., 2018)  DOI: 10.1038/s41586-018-0439-x

Immunological & Inflammatory Diseases

Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis. (Arias-de la Rosa I et al.,2023) 

DOI: 10.1016/j.ejim.2023.08.002

Elevation of IL-17 cytokines distinguishes Kawasaki disease from other pediatric inflammatory disorders. (Brodeur KE et al., 2023) 

DOI: 10.1002/art.42680

Increased plasma levels of soluble programmed death ligand 1 (sPD-L1) and fibroblast growth factor 23 (FGF-23) in patients with Graves’ ophthalmopathy in comparison to hyperthyroid patients without Graves’ ophthalmopathy. (Khamisi et al., 2023) Cytokine

DOI: 10.1016/j.cyto.2023.156269

Exploring proteomic plasma biomarkers in eosinophilic and neutrophilic asthma. (Kere M et al., 2022) 

DOI: 10.1111/cea.14229


Dobilas A, Åkesson A, Leandersson P, et al. A Multiplex Biomarker Assay Improves the Prediction of Survival in Epithelial Ovarian Cancer. (2023) Cancer Genomics & Proteomics, 

DOI: 10.21873/cgp.20380

Gyllensten U, Hedlund-Lindberg J, Svensson J, et al. Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer. (2022) Cancers

DOI: 10.3390/cancers14071757

Mukama T, Fortner RT, Katzke V, et al. Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer. (2022) British Journal of Cancer

DOI: 10.1038/s41416-021-01697-z

Sabaa AA, Shen Q, Lennmyr EB, et al. Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls. (2022) New Biotechnoogy

DOI: 10.1016/j.nbt.2022.06.005

Urbiola-Salvador V, Miroszewska D, Jabłońska A, et al. Proteomics approaches to characterize the immune responses in cancer. (2022) Biochimica et Biophysica Acta Molecular Cell Research

DOI: 10.1016/j.bbamcr.2022.119266

Chen H, Qian J, Werner S, Cuk K, Knebel P and Brenner H. Development and validation of a panel of five proteins as blood biomarkers for early detection of colorectal cancer. (2017) Clinical Epidemiology

DOI: 10.2147/CLEP.S144171

Qian J, Tikk K, Werner S, Balavarca Y, Saadat M, Hechtner M and Brenner H. Biomarker discovery study of inflammatory proteins for colorectal cancer early detection demonstrated importance of screening setting validation.(2018) Journal of Clinical Epidemiology

DOI: 10.1016/j.jclinepi.2018.07.016

Tromp J, Boerman L, Sama I, Maass S, Maduro J, Hummel Y, Berger M, de Bock G, Gietema J, Berendsen A and van der Meer P. Long‐term survivors of early breast cancer treated with chemotherapy are characterized by a pro‐inflammatory biomarker profile compared to matched controls (2020) European Journal of Heart Failure

DOI: 10.1002/ejhf.1758

The list provided is non exhaustive, click here to learn more.